370
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Calprotectin in patients with chronic rheumatoid arthritis correlates with disease activity and responsiveness to methotrexate

, , , &
Pages 62-67 | Received 21 Jul 2017, Accepted 02 Dec 2017, Published online: 11 Dec 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jiashun Zeng, Xiaoxia Liu, Jun Liu, Pengjia Wu & Lei Yang. (2022) Linkage of Calprotectin with Inflammation, Activity and Treatment Response of Rheumatoid Arthritis: A Meta-Analysis. Biomarkers in Medicine 16:17, pages 1239-1249.
Read now
Michael Mahler, Pier-Luigi Meroni, Maria Infantino, Katherine A. Buhler & Marvin J. Fritzler. (2021) Circulating Calprotectin as a Biomarker of COVID-19 Severity. Expert Review of Clinical Immunology 17:5, pages 431-443.
Read now
Anne Incamps, Celia Saez-Boiteau, Svenja Lena Tiede, Pauline Rebillard, Janin Schulte, Jérôme Vialaret, Andre Beinrucker, Sylvain Lehmann & Christophe Hirtz. (2018) Impact of Biological Matrix on Inflammatory Protein Biomarker Quantification Based on Targeted Mass Spectrometry. Bioanalysis 10:17, pages 1383-1399.
Read now

Articles from other publishers (15)

Sarah Sayed El-Tawab, Lamya Mohamed Moharram, Gihan Abdellatif Younis, Nermeen Ahmed EL Dabah & Hoda Mohamed Adel-Naby. (2024) Study of serum calprotectin level in rheumatoid arthritis: unexpected low level and possible explanations. Egyptian Rheumatology and Rehabilitation 51:1.
Crossref
Mahadevappa Hemshekhar, Dylan Lloyd, Hani El-Gabalawy & Neeloffer Mookherjee. (2023) A bioavailable form of curcumin suppresses cationic host defence peptides cathelicidin and calprotectin in a murine model of collagen-induced arthritis. Arthritis Research & Therapy 25:1.
Crossref
Samantha Louise Smith, Sheree Alexander, Nisha Nair, Sebastien Viatte, Stephen Eyre, Kimme L Hyrich, Ann W Morgan, Anthony G Wilson, John D Isaacs, Darren Plant & Anne Barton. (2023) Pre-treatment calprotectin (MRP8/14) provides no added value to testing CRP alone in terms of predicting response to TNF inhibitors in rheumatoid arthritis in a post hoc analysis. Annals of the Rheumatic Diseases 82:5, pages 611-620.
Crossref
Benoît Thomas P. Gilbert, Céline Lamacchia, Lena Amend, Till Strowig, Emiliana Rodriguez, Gaby Palmer & Axel Finckh. (2023) Brief report: Assessment of mucosal barrier integrity using serological biomarkers in preclinical stages of rheumatoid arthritis. Frontiers in Immunology 14.
Crossref
Lena Amend, Benoît Thomas P. Gilbert, Penelope Pelczar, Marius Böttcher, Samuel Huber, Torsten Witte, Axel Finckh & Till Strowig. (2023) Characterization of serum biomarkers and antibody responses against Prevotella spp. in preclinical and new-onset phase of rheumatic diseases. Frontiers in Cellular and Infection Microbiology 12.
Crossref
José Inciarte-Mundo, Beatriz Frade-Sosa & Raimon Sanmartí. (2022) From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis. Frontiers in Immunology 13.
Crossref
Maria Giovanna Danieli, Eleonora Antonelli, Mario Andrea Piga, Ilaria Claudi, Davide Palmeri, Alessandro Tonacci, Alessandro Allegra & Sebastiano Gangemi. (2022) Alarmins in autoimmune diseases. Autoimmunity Reviews 21:9, pages 103142.
Crossref
Margherita Scapaticci, Andrea Bartolini, Marta Biscaro, Renzo Biscaro & Giorgio Da Rin. (2022) Interleukin-6 and Serum/Fecal Calprotectin as Useful Specific Markers for Monitoring Rheumatic Diseases: A Pilot Study. Laboratory Medicine 53:2, pages 123-127.
Crossref
Irene Di Ceglie, Peter L. E. M. van Lent, Edwin J. W. Geven, Marije I. Koenders, Arjen B. Blom, Thomas Vogl, Johannes Roth & Martijn H. J. van den Bosch. (2021) S100A8/A9 is not essential for the development of inflammation and joint pathology in interleukin-1 receptor antagonist knockout mice. Arthritis Research & Therapy 23:1.
Crossref
Ahmed R. Radwan, Ahmed Allam & Abdullah Radwan. (2021) The relationship of serum calprotectin with disease activity, functional status, ultrasonographic findings and radiological damage in rheumatoid arthritis patients. The Egyptian Rheumatologist 43:2, pages 147-151.
Crossref
Hongyu Gao, Jingling Xu, Lu He, Huanxin Meng & Jianxia Hou. (2020) Calprotectin levels in gingival crevicular fluid and serum of patients with chronic periodontitis and type 2 diabetes mellitus before and after initial periodontal therapy. Journal of Periodontal Research 56:1, pages 121-130.
Crossref
Matthias Jarlborg, Delphine S. Courvoisier, Céline Lamacchia, Laura Martinez Prat, Michael Mahler, Chelsea Bentow, Axel Finckh, Cem Gabay & Michael J. Nissen. (2020) Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis. Arthritis Research & Therapy 22:1.
Crossref
Mahadevappa Hemshekhar, Hadeesha Piyadasa, Dina Mostafa, Leola N. Y. Chow, Andrew J. Halayko & Neeloffer Mookherjee. (2020) Cathelicidin and Calprotectin Are Disparately Altered in Murine Models of Inflammatory Arthritis and Airway Inflammation. Frontiers in Immunology 11.
Crossref
Irene Di Ceglie, Nik N L Kruisbergen, Martijn H J van den Bosch & Peter L E M van Lent. (2019) Fc-gamma receptors and S100A8/A9 cause bone erosion during rheumatoid arthritis. Do they act as partners in crime?. Rheumatology 58:8, pages 1331-1343.
Crossref
Judith Austermann, Christoph Spiekermann & Johannes Roth. (2018) S100 proteins in rheumatic diseases. Nature Reviews Rheumatology 14:9, pages 528-541.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.